Table 3.

Inhibition of Platelet Adhesion to Human Collagen Type I and III by CRPs in the Presence of dRGDW Under Flow Conditions

Collagen I Collagen III
Control 31.6 ± 1.0 (n = 43)  41.4 ± 0.8 (n = 37)  
+CRP 1  21.2 ± 1.2 (n = 16)  24.1 ± 1.0 (n = 17) 
+CRP 1-XL  14.8 ± 0.8 (n = 7) 20.0 ± 0.8 (n = 8)  
+CRP 2  28.9 ± 1.7 (n = 10) 27.5 ± 1.3 (n = 3)  
+CRP 2-XL 13.6 ± 0.7 (n = 10)  13.1 ± 1.0 (n = 3) 
Collagen I Collagen III
Control 31.6 ± 1.0 (n = 43)  41.4 ± 0.8 (n = 37)  
+CRP 1  21.2 ± 1.2 (n = 16)  24.1 ± 1.0 (n = 17) 
+CRP 1-XL  14.8 ± 0.8 (n = 7) 20.0 ± 0.8 (n = 8)  
+CRP 2  28.9 ± 1.7 (n = 10) 27.5 ± 1.3 (n = 3)  
+CRP 2-XL 13.6 ± 0.7 (n = 10)  13.1 ± 1.0 (n = 3) 

Data are expressed as the percentage of surface covered with platelets. The control perfusions were performed with dRGDW (200 μmol/L) alone present. The other perfusions were performed with both dRGDW and CRPs present. CRP 1 and 2 (free peptide or cross-linked) were added at a concentration of 100 μg/mL in whole blood. Collagens were human placental monomeric collagens. The perfusion experiments were performed at 300 s−1. Values are the mean ± SEM (n = number of evaluated coverslips) and were obtained in at least two independent experiments.

or Create an Account

Close Modal
Close Modal